Compare Deere & Company (DE) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deere & Company vs TransMedics Group Inc — how do they compare? Deere & Company trades at $618 (market cap $166.81B), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: Deere & Company is far larger — about 53.8× TransMedics Group Inc's market cap, and Deere & Company pays a 1.05% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| DE | TMDX | |
|---|---|---|
Market Cap | $166.81B | $3.10B |
Sector | Industrials | Technology |
52-Week High | $662.49 | $150.42 |
52-Week Low | $439.11 | $61.99 |
Enterprise Value | $221.63B | $3.49B |
Dividend Yield | 1.05% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deere & Company
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
Read more on DE →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
